Pharmaceutical composition

PH12021552500B1Active Publication Date: 2026-11-06ASTELLAS PHARMA INC
0 Cites 0 Cited by

Patent Information

Application Number
PH12021552500
Authority / Receiving Office
PH · PH
Patent Type
Patents
Current Assignee / Owner
Filing Date
2021-10-01
Publication Date
2026-11-06
Estimated Expiration
2041-10-01
Patent Text Reader

Abstract

Provided is a pharmaceutical composition containing 6-ethyl-3-{3-methoxy-4-[4-(4methylpiperazin-1-yl)piperidin-1-yl]anilino}-5-[(oxan-4-yl)amino]pyrazine-2carboxamide or a pharmaceutically acceptable salt thereof and a sweetener for reducing the bitterness of gilteritinib, suppressing the decrease in dissolution stability of gilteritinib due to, for example, stress such as heat and / or humidity over time, and having excellent dissolution stability. The pharmaceutical composition contains gilteritinib or a pharmaceutically acceptable salt thereof, a sweetener, and sugars and / or sugar alcohols.
Need to check novelty before this filing date? Find Prior Art